Research

At the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, physicians from the Fox Chase Cancer Center Radiation Oncology Department shared new research and clinical insights that underscored the future of radiation-based cancer care. Their presentations highlighted accurate radiation planning, treatment deintensification and advances in the field.

Mitchell Fane, PhD and his team at Fox Chase Cancer Center are rethinking one of the most understudied and university cancer risk factors: aging. Their investigations could reshape our understanding of why cancers become more aggressive and harder to treat as our immune systems age.

Researchers at Fox Chase Cancer Center have identified a promising new approach to rebuilding tissue after skin cancer surgery that could help some patients avoid more extensive reconstructive procedures.

The study found that epigenetic changes can reshape DNA organization in ways that may influence future cancer treatments.

A large national study led in part by researchers at Fox Chase Cancer Center has found that stomach cancer patients who respond especially well to chemotherapy given before surgery live significantly longer than those who do not.

A new international research collaboration led by investigators at Fox Chase Cancer Center and The University of Alabama is working to improve outcomes for patients with metastatic colorectal cancer by expanding representation in cancer research and identifying biological markers that may influence survival.

Sid Balachandran, PhD arrived in America with $97 and two suitcases. Decades later, his curiosity about how flu viruses kill cells led to an unexpected discovery that could help the immune system finally recognize and destroy cancer.

Fox Chase Cancer Center researchers found that adding an FDA-approved thyroid hormone after chemotherapy helped prevent tumor regrowth in laboratory and animal studies. This approach is now being tested in a national pediatric clinical trial for medulloblastoma.